The Aldehyde Dehydrogenase 2 rs671 Variant Enhances Platelet Activation and Arterial Thrombosis
Circulation · 2026
DOI: 10.1161/circulationaha.125.074318 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation, 2026. Verfasst von Song Sun und 13 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Emergency Medicine, Qilu Hospital of Shandong University, Jinan, Shandong, China (S.S., X. Zhang, H.Y., C.F., Y.G., X.L., S.C., K.Y., …. Hauptthemen laut MEDLINE: Aldehyde Dehydrogenase, Mitochondrial, Platelet Activation, Thrombosis, Blood Platelets. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: Acute myocardial infarction (AMI) caused by thrombosis is a major cause of mortality. A polymorphism in Aldh2 gene (rs671) is found in approximately 30% to 50% of East Asians, and it is a risk factor for AMI. This mutation impairs aldehyde dehydrogenase 2 (ALDH2) function, but the effect of ALDH2 on platelet activation and thrombosis is unknown. METHODS: Platelets were isolated from platelet-specific Aldh2 knockout ( Aldh2 -/- ) and ALDH2 E506K knock-in mice (which corresponds to human Aldh2 rs671 gene mutation), as well as from healthy human donors with the Aldh2 rs671. Arterial thrombosis was measured in a FeCl 3 -induced thrombosis mouse model. The efficacy of Alda-1, an ALDH2 activator, in mitigating thrombogenesis was measured in ALDH2 E506K mice. Using a murine model of myocardial infarction (MI) model, we analyzed the effects of platelet Aldh2 on micro-thrombosis and infarct expansion post-MI. In addition, we enrolled 118 patients of different Aldh2 rs671 genotypes (GG, GA, and AA) diagnosed with ST elevation myocardial infarction (STEMI) to analyze the association between rs671 genotype and platelet activation and thrombosis. RESULTS: Platelets from Aldh 2 -/- and ALDH2 E506K mice showed enhanced agonist induced aggregation, ATP release, integrin αIIbβ3 activation, P-selectin release, spreading, and clot retraction. Human platelets with the Aldh2 rs671 variant also exhibited increased activation. Mutation of Aldh2 or platelet-specific knockout of Aldh2 exacerbated thrombus formation in a mouse model of thrombosis. The ALDH2 activator, Alda-1, reduced thrombosis in ALDH2 E506K mice. We explored pathways mediating the effect of Aldh2 on platelet activation. We found that platelets lacking Aldh2 produced more reactive oxygen species (ROS) and less nitric oxide (NO) than wild-type platelets. Furthermore, platelets lacking Aldh2 are also more susceptible to activation by aldehydes. Additionally, platelets from mice lacking Aldh2 had increased elevated mitophagy and hyperactivity. ACAD10 mediated some of the effects of ALDH2 on mitophagy. Mice lacking Aldh2 had increased micro-thrombosis and myocardial infarct expansion. Finally, elevated platelet activation and thrombus markers were also observed in plasma from patients with STEMI patients who had the rs671 variant. CONCLUSIONS: The Aldh2 rs671 variant, which impairs ALDH2 function, increases platelet activation and thrombus formation in vivo through aldehyde accumulation and ROS buildup. Abnormal ACAD10 homeostasis might also contribute to this hyperactivity via enhancing platelet mitophagy. Our findings suggest the potential of ALDH2 as a novel antiplatelet target. Future studies are needed to explore the effects of more aggressive antiplatelet therapy for patients at risk of MI who carry the Aldh2 rs671 mutation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departments of Emergency Medicine, Qilu Hospital of Shandong University, Jinan, Shandong, China (S.S., X. Zhang, H.Y., C.F., Y.G., X.L., S.C., K.Y., X. Zhao, C.P., F.X., Y.C.).
- Department of Clinical Laboratory (S.S., Y.Z.), Qilu Hospital of Shandong University, Jinan, Shandong, China.
- Shandong Provincial Clinical Research Center for Emergency and Critical Care Medicine, Institute of Emergency and Critical Care Medicine of Shandong University, Chest Pain Center, Qilu Hospital of Shandong University, J…
- Medical and Pharmaceutical Basic Research Innovation Center of Emergency and Critical Care Medicine, China's Ministry of Education, Shandong Provincial Engineering Laboratory for Emergency and Critical Care Medicine, Ke…
- NMPA Key Laboratory for Clinical Research and Evaluation of Innovative Drugs, Qilu Hospital of Shandong University, Jinan, Shandong, China (S.S., X. Zhang, H.Y., C.F., Y.G., X.L., S.C., K.Y., X. Zhao, C.P., F.X., Y.C.).
- National Key Laboratory for Innovation and Transformation of Luobing Theory; The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission and C…
ORCID-Profile: Song Sun, Hongwei Yue, Cuiqin Fan, Yi Zhang, Sumei Cui, Kehui Yang, Xiangkai Zhao, Cheng Zhang, Feng Xu, Yuguo Chen
Zitieren
APA
Sun, S., Zhang, X., Yue, H., Fan, C., Zhang, Y., Guo, Y., Li, X., Cui, S., Yang, K., Zhao, X., Zhang, C., Pan, C., Xu, F., & Chen, Y. (2026). The Aldehyde Dehydrogenase 2 rs671 Variant Enhances Platelet Activation and Arterial Thrombosis. Circulation. https://doi.org/10.1161/circulationaha.125.074318
Vancouver
Sun S, Zhang X, Yue H, Fan C, Zhang Y, Guo Y, et al. The Aldehyde Dehydrogenase 2 rs671 Variant Enhances Platelet Activation and Arterial Thrombosis. Circulation. 2026. doi:10.1161/circulationaha.125.074318
BibTeX
@article{Sun2026,
author = {Sun, Song and Zhang, Xuan and Yue, Hongwei and Fan, Cuiqin and Zhang, Yi and Guo, Yunyun and Li, Xingming and Cui, Sumei and Yang, Kehui and Zhao, Xiangkai and Zhang, Cheng and Pan, Chang and Xu, Feng and Chen, Yuguo},
title = {The Aldehyde Dehydrogenase 2 rs671 Variant Enhances Platelet Activation and Arterial Thrombosis},
journal = {Circulation},
year = {2026},
doi = {10.1161/circulationaha.125.074318}
}
EUVIMED